Retrieval's ORIGENICS Enters Impact Pitch of GenAI/SUM 2025
Retrieval Inc. Advances in GenAI/SUM 2025
Retrieval Inc., headquartered in Toshima, Tokyo, has made significant strides in the medical industry with its innovative product, ORIGENICS. This platform has recently successfully advanced to the first round of the Impact Pitch at the GenAI/SUM 2025 summit, hosted by Nikkei Inc. This event centers on the future of AI in various sectors, including economy, society, and education.
Addressing Critical Challenges in Drug Development
Nucleic acid medicines, which are designed to interact directly with target genes causing diseases, have a promising future, especially for difficult-to-treat ailments and rare diseases. However, the road to developing these medicines is fraught with challenges. The process often stretches over a decade and can cost hundreds of millions to billions of yen, with a success probability estimated at just 1 in 25,000.
Particularly in the field of nucleic acid drugs, the predictive accuracy of computational methods remains underdeveloped. Discrepancies between experimental results and predictions can lead to increased costs and extended timelines due to trial and error. To address these pressing concerns, Retrieval developed the ORIGENICS platform, aiming to streamline and enhance the drug discovery process.
Overview of ORIGENICS
The ORIGENICS platform is uniquely designed to support the comprehensive development of nucleic acid medicines. It excels at ensuring high effectiveness against target genes while minimizing off-target effects, which is crucial for developing potent and safe therapeutic options. By utilizing ORIGENICS, researchers can significantly improve their chances of success in drug development, ensuring that new treatments reach patients as quickly as possible.
Retrieval’s mission is to leverage ORIGENICS to alleviate the existing burdens in drug development and to facilitate the timely delivery of innovative medicines to those in need. The company firmly believes in the transformative potential of AI technology in the realm of healthcare.
GenAI/SUM 2025 Impact Pitch Details
The GenAI/SUM 2025 summit is a prestigious event that showcases pioneering startups from both Japan and abroad. With the theme of "AI Co-creation: A Vision for the Future of Economy, Society, and Education," selected finalists, including Retrieval, will present their innovative solutions to an audience of industry leaders and stakeholders.
Event Information
- - Date: October 6 - 8, 2025
- - Location: Kudanshita Conference & Banquet Hall
- - Host: Nikkei Inc.
- - Registration and Details: GenAI/SUM Website
Support and Voting
An exciting feature of the event is the opportunity for public participation through support voting. The voting period runs from August 27 to September 8, where supporters can cast their votes on the official website for their favorite startups, including Retrieval.
About Retrieval Inc.
Founded on the principle of supporting people through AI technology, Retrieval Inc. focuses on providing AI solutions tailored for businesses, utilizing large language models and generative AI. The company is committed to enhancing the efficacy of natural language processing applications, including RAG and AI agent development.
- - Headquarters: WeWork, Metropolitan Plaza Building 14F, 1-11-1 Nishikebukuro, Toshima, Tokyo
- - CEO: Takuya Taguchi
- - Website: Retrieval Corporate Site
For inquiries regarding this matter, please contact:
Retrieval Inc.
Email: [email protected]
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.